Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
2 mg | 在庫あり | ¥ 8,500 | |||
5 mg | 在庫あり | ¥ 13,500 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 41,000 | |||
50 mg | 在庫あり | ¥ 73,000 | |||
100 mg | 在庫あり | ¥ 108,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,500 |
説明 | Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes. |
別名 | Gd-EOB-DTPA Disodium, ZK 139834 |
分子量 | 725.71 |
分子式 | C23H28GdN3Na2O11 |
CAS No. | 135326-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.03 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gadoxetate Disodium 135326-22-6 Others Inhibitor Gd-EOB-DTPA Disodium ZK-139834 Gadoxetate ZK139834 Gd-EOB-DTPA ZK 139834 inhibit inhibitor